New appointment at Astellas Pharma Europe
This article was originally published in Scrip
Jerry Temko has been named senior vice-president and general counsel atAstellas Pharma Europe. He is also chief compliance officer for the European region. Mr Temko joined Yamanouchi in 2003, before the company's merger with Fujisawa which created Astellas Pharma.
You may also be interested in...
The Phase III FIDELIO trial of finerenone has been a success but analysts want to see some actual data before declaring it an unqualified one.
Gilead says remdesivir improved mortality and clinical recovery in COVID-19 patients, but the findings come from a retrospective analysis, not a traditional clinical trial.
Agency resuming domestic inspections with the help of a pandemic rating system to identify localities where inspections will be safest for investigators and plant workers. Another safety factor: all inspections will be pre-announced.